Revvity (Perkinelmer) - Fetal Medicine Approved.
Revvity (Perkinelmer) – Fetal Medicine Approved.
Revvity first trimester assays for Free hCGB, PAPP-A, AFP and PIGF on the AutoDELFIA and DELFIA Xpress platforms and DELFIA/Auto DELFIA PAPP- A/Free hCGB Dual DBS assay are approved by the Fetal Medicine Foundation (FMF)
Revvity’s prenatal screening assays are all clinically validated and can be run on any of our 3 scaleable platforms. Using the right markers combined with LifeCycle, our industry leading risk calculation software, laboratories can offer optimised screening to all patients. Our screening solutions are also used in many international prenatal and maternal health studies,
- Double Marker
- 1T-Quad Marker
- Triple Marker
- Quadruple Marker
- Pre-Eclampsia
- NIPT
Why Raos Pathlab HO Labs
NABL Accredited Labs
Trusted by Leading Doctors & hospitals
Shortest Reporting Time
Accurate Test Reports
Large Network 100+ Labs
3000+ Collection Centres
Frequently Asked Questions
1. What is prenatal screening?
Prenatal screening is a set of tests performed during pregnancy to assess the risk of certain chromosomal abnormalities, birth defects, and pregnancy-related complications in the developing baby.
2. What is the Double Marker test?
The Double Marker test is a first-trimester screening that measures Free hCGβ and PAPP-A levels in the mother’s blood to assess the risk of chromosomal conditions such as Down syndrome.
3. What prenatal screening tests are available?
We offer Double Marker, 1T-Quad Marker, Triple Marker, Quadruple Marker, Pre-Eclampsia Screening, and NIPT.
4. What is NIPT?
NIPT (Non-Invasive Prenatal Testing) analyzes fetal DNA from the mother’s blood to screen for common chromosomal abnormalities.
5. Why choose Rao's Pathlab for prenatal screening?
Rao’s Pathlab uses FMF-approved Revvity screening solutions, advanced technology, and validated testing methods for accurate and reliable results.
